82 related articles for article (PubMed ID: 20193751)
21. Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.
Qi F; Li A; Inagaki Y; Kokudo N; Tamura S; Nakata M; Tang W
Int Immunopharmacol; 2011 Mar; 11(3):342-9. PubMed ID: 21185919
[TBL] [Abstract][Full Text] [Related]
22. Identification of potential anti-tumor targets and mechanisms of HuaChanSu injection using network pharmacology and cytological experiments in Breast cancer.
Yang Z; Wang Y; Huang S; Geng Y; Yang Z; Yang Z
PLoS One; 2024; 19(5):e0303650. PubMed ID: 38753638
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and Safety of Hepatic Arterial Infusion Therapy with Cinobufacini in Advanced Hepatocellular Carcinoma with Macrovascular Invasion: A Retrospective Cohort Study.
Xue T; Yu H; Feng W; Wang Y; Wu S; Wang L; Zhu P; Guan J; Sun Q
Cancer Manag Res; 2024; 16():163-175. PubMed ID: 38505102
[TBL] [Abstract][Full Text] [Related]
24. Targeting Dysregulated Ion Channels in Liver Tumors with Venom Peptides.
Achimba F; Faezov B; Cohen B; Dunbrack R; Holford M
Mol Cancer Ther; 2024 Feb; 23(2):139-147. PubMed ID: 38015557
[TBL] [Abstract][Full Text] [Related]
25. Effect of Cinobufacini plus platinum-based chemotherapy regimen on the immune function of patients with non-small-cell lung cancer: A meta-analysis.
Zhao Y; Zhu D; Wu Z; Bai L; Wang D; Xu Y; Zhou X
Heliyon; 2023 Oct; 9(10):e20349. PubMed ID: 37767473
[TBL] [Abstract][Full Text] [Related]
26. Alisol B 23-Acetate Increases the Antitumor Effect of Bufalin on Liver Cancer through Inactivating Wnt/
Ye M; Tang Y; He J; Cao X; Liu J; Kou S; Yang Y; Xue J; Li F
Comput Math Methods Med; 2022; 2022():6249534. PubMed ID: 35572840
[TBL] [Abstract][Full Text] [Related]
27. Cinobufacini Injection Inhibits the Proliferation of Triple-Negative Breast Cancer Through the Pin1-TAZ Signaling Pathway.
Kong L; Liu X; Yu B; Yuan Y; Zhao Q; Chen Y; Qu B; Du X; Tian X; Shao R; Wang Y
Front Pharmacol; 2022; 13():797873. PubMed ID: 35450041
[TBL] [Abstract][Full Text] [Related]
28. Meta-Analysis of Therapy of Cinobufacini Capsule Adjunct with First-Line Platinum-Based Chemotherapy for the Treatment of Advanced NSCLC.
Peng W; Xu Y; Feng F; Gu C; Wang Z; Han D; Zhou X; He H
Evid Based Complement Alternat Med; 2021; 2021():5596415. PubMed ID: 34471417
[TBL] [Abstract][Full Text] [Related]
29. Acetyl-bufalin shows potent efficacy against non-small-cell lung cancer by targeting the CDK9/STAT3 signalling pathway.
Yang L; Zhou F; Zhuang Y; Liu Y; Xu L; Zhao H; Xiang Y; Dai X; Liu Z; Huang X; Wang L; Zhao C
Br J Cancer; 2021 Feb; 124(3):645-657. PubMed ID: 33122847
[TBL] [Abstract][Full Text] [Related]
30. Bufalin attenuates triple-negative breast cancer cell stemness by inhibiting the expression of SOX2/OCT4.
Chen F; Zhu L; Hu J; Jiang S; Liu H; Zheng J; Wang J; Wang F; Li Z
Oncol Lett; 2020 Nov; 20(5):171. PubMed ID: 32934738
[TBL] [Abstract][Full Text] [Related]
31. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines.
An W; Lai H; Zhang Y; Liu M; Lin X; Cao S
Front Pharmacol; 2019; 10():758. PubMed ID: 31354479
[TBL] [Abstract][Full Text] [Related]
32. Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells.
Li J; Rong MH; Dang YW; He RQ; Lin P; Yang H; Li XJ; Xiong DD; Zhang LJ; Qin H; Feng CX; Chen XY; Zhong JC; Ma J; Chen G
Mol Med Rep; 2019 May; 19(5):4256-4270. PubMed ID: 30896874
[TBL] [Abstract][Full Text] [Related]
33. The Ethanol Supernatant Extracts of Liushenwan Could Alleviate Nanodiethylnitrosamine-Induced Liver Cancer in Mice.
Chen XZ; Zhang WK; Tang HB; Li XJ; Tian GH; Shang HC; Li YS
Can J Gastroenterol Hepatol; 2018; 2018():6934809. PubMed ID: 30356380
[TBL] [Abstract][Full Text] [Related]
34. Bufalin Enhances the Cytotoxity of Human Multiple Myeloma Cells H929 to AKT Inhibitor MK2206: The Role of Protein AKT Phosphorylation.
Huang H; Lin XJ; Lin Y; Yao RX; He MQ
Indian J Hematol Blood Transfus; 2018 Apr; 34(2):268-272. PubMed ID: 29622868
[TBL] [Abstract][Full Text] [Related]
35. Riparsaponin isolated from
Li T; Wang L
Oncol Lett; 2017 Dec; 14(6):6841-6846. PubMed ID: 29163704
[No Abstract] [Full Text] [Related]
36. Delisheng induces antiproliferation and apoptosis effects in Hep3B cells via modulation of angiogenic proteins.
Sun HF; Jing L; Wu T; Li M; Guo YH; Guo H; Zhao Z; Wang MC; Wang SH; Nan KJ
Oncol Lett; 2017 Dec; 14(6):6578-6584. PubMed ID: 29163690
[TBL] [Abstract][Full Text] [Related]
37. [Cinobufagin treatment of relapsed or refractory hematological malignant tumor: 8 cases report and literatures review].
Wang L; Mi R; Wei X; Chen L; Ai H; Yin Q; Wang P
Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):954-6. PubMed ID: 26632471
[No Abstract] [Full Text] [Related]
38. Application of eupatilin in the treatment of osteosarcoma.
Li YY; Wu H; Dong YG; Lin BO; Xu G; Ma YB
Oncol Lett; 2015 Oct; 10(4):2505-2510. PubMed ID: 26622880
[TBL] [Abstract][Full Text] [Related]
39. Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.
Ye L; Jia Y; Ji KE; Sanders AJ; Xue K; Ji J; Mason MD; Jiang WG
Oncol Lett; 2015 Sep; 10(3):1240-1250. PubMed ID: 26622657
[TBL] [Abstract][Full Text] [Related]
40. Arenobufagin intercalates with DNA leading to G2 cell cycle arrest via ATM/ATR pathway.
Deng LJ; Peng QL; Wang LH; Xu J; Liu JS; Li YJ; Zhuo ZJ; Bai LL; Hu LP; Chen WM; Ye WC; Zhang DM
Oncotarget; 2015 Oct; 6(33):34258-75. PubMed ID: 26485758
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
